Aarti Drugs Limited (ADL), part of the Aarti Group, is a leading manufacturer of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals. Founded in 1984, the company has established itself as a market leader with a diverse product portfolio spanning Antibiotics, Anti-Protozoal, Anti-Inflammatory, Anti-diabetic, Anti-Fungal, and Cardioprotectant segments. ADL operates multiple manufacturing units and two R&D centers in Maharashtra, all GMP certified, ensuring high-quality production standards.
The company has expanded its capacity significantly over the years, with notable expansions in the 2000s and strategic acquisitions, including Suyash Laboratories Ltd. It also formed joint ventures such as Huanggang Yinhe Aarti Pharmaceutical Company Ltd in China to enhance its global presence. ADL's wholly-owned subsidiaries include Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited. In 2022, the company further bolstered its capabilities with a brownfield expansion of its Specialty Chemical Plant in Tarapur.
